{"id":"W2588936898","doi":"10.1200/jco.2005.23.16_suppl.7018","title":"Symptom response in non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib: Quality of life analysis of the NCIC CTG BR.21 trial","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Erlotinib; Clinical endpoint; Quality of life (healthcare); Internal medicine; Placebo; Lung cancer; Palliative care; Discontinuation; Randomized controlled trial; Cancer; Pathology; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002471733,0.00111187,0.002027171,0.0003116772,0.000326287,0.00087278,0.0006102744,0.001145486,0.003303112],"category_scores_gemma":[0.001745325,0.0003047103,0.001918585,0.000463548,0.0005404065,0.0004596105,0.000396359,0.001766336,0.0004858201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008383424,"about_ca_system_score_gemma":0.0008350465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011875,"about_ca_topic_score_gemma":0.002424902,"domain_scores_codex":[0.9991168,0.0006048566,0.00005634483,0.00008071394,0.00007389935,0.00006742385],"domain_scores_gemma":[0.9990178,0.00022868,0.0003306915,0.00005574579,0.00005976716,0.0003072188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.948788,0.005568797,0.009667733,0.001221772,0.003031277,0.00007353919,0.00005933841,0.0007241009,0.002829712,0.00007554115,0.00304967,0.02491043],"study_design_scores_gemma":[0.8044267,0.1314939,0.05660547,0.000114411,0.003321288,0.0001806804,0.00003352773,0.0009287993,0.0005566685,0.0001369816,0.002166482,0.00003503657],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855605,0.008223497,0.0001817502,0.0006496561,0.000122185,0.001267737,0.002249646,0.00004282432,0.001702209],"genre_scores_gemma":[0.9890925,0.002635915,0.0003578888,0.0008271693,0.0002473944,0.001719254,0.004096303,0.00001186265,0.001011707],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003303112,"threshold_uncertainty_score":0.01307189,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06928640520948959,"score_gpt":0.4854674319942019,"score_spread":0.4161810267847124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}